Transcriptomic Profiling Identifies Ferroptosis-Related Gene Signatures in Ischemic Muscle Satellite Cells Affected

Lillian Tran1, Bowen Xie1, Edwyn Assaf1

  • 1Department of Surgery, University of Pittsburgh Medical Center, PA (L.T., B.X., E.A., R.F., R.I.M.A., U.S.).

Abstract

Insights

Peripheral artery disease (PAD) muscle satellite cells show increased ferroptosis markers, suggesting this programmed cell death pathway contributes to skeletal muscle myopathy. Targeting ferroptosis may offer a new therapeutic approach for PAD.

Area of Science:

  • Cellular Biology
  • Molecular Medicine
  • Pathophysiology

Background:

  • Peripheral artery disease (PAD) is associated with skeletal muscle myopathy.
  • The specific molecular pathways contributing to PAD-induced myopathy are not fully understood.
  • Ferroptosis, a form of programmed cell death involving iron-mediated lipid peroxidation, is implicated in cardiac myopathy but its role in PAD is unknown.

Purpose of the Study:

  • To investigate transcriptomic profiles of muscle satellite cells in PAD patients.
  • To identify damage-related pathways contributing to skeletal muscle myopathy in PAD.
  • To explore the potential role of ferroptosis in PAD-associated myopathy.

Main Methods:

  • Single-cell RNA sequencing of muscle satellite cells from PAD donors.
  • Analysis of gene expression patterns to identify cell populations and pathways.
  • Confirmation of protein expression and pathway inference.
  • Histological analysis for iron deposition and lipofuscin.

Main Results:

  • Distinct cell populations were identified, with diminished quiescent cells and increased myofibroblasts and apoptotic cells in ischemic muscle.
  • Genes associated with iron transport and oxidative stress were upregulated, while GPX4 expression decreased in PAD-derived cells.
  • Ferroptotic markers, including HMGB1 release and transferrin receptor expression, were elevated in ischemic muscle.
  • Iron deposition and lipofuscin were confirmed in PAD-affected muscle tissue.

Conclusions:

  • Genes involved in ferroptosis are differentially expressed in human skeletal muscle affected by PAD.
  • Ferroptosis plays a significant role in the skeletal muscle myopathy observed in PAD.
  • Targeting ferroptosis presents a novel therapeutic strategy for mitigating PAD-related myopathy.